Claims for Patent: 9,987,261
✉ Email this page to a colleague
Summary for Patent: 9,987,261
Title: | Substituted diazaspiroalkanes as androgen receptor modulators |
Abstract: | Described herein, inter alia, are compounds useful for the prevention or treatment of hyperproliferative diseases or disorders. |
Inventor(s): | Jung; Michael E. (Los Angeles, CA), Sawyers; Charles L. (New York, NY), Ouk; Samedy (Los Angeles, CA), Tran; Chris (New York, NY), Wongvipat; John (New York, NY) |
Assignee: | The Regents of the University of California (Oakland, CA) |
Application Number: | 15/181,030 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,987,261 |
Patent Claims: |
1. A capsule comprising a compound having a formula: ##STR00025## or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, diluent, or adjuvant.
2. The capsule of claim 1, wherein the capsule is coated with gelatin, wax, shellac, or sugar, or a combination thereof. 3. The capsule of claim 1, wherein the capsule comprises the compound having a formula: ##STR00026## 4. The capsule of claim 1, wherein the capsule comprises the compound having a formula: ##STR00027## 5. The capsule of claim 1, wherein the capsule comprises the compound having a formula: ##STR00028## in a range of from 0.0005 to 500 mg. 6. The capsule of claim 1, wherein the capsule comprises the compound having a formula: ##STR00029## in a range of from 0.01 to 50 mg. 7. The capsule of claim 1, wherein the capsule comprises the compound having a formula: ##STR00030## in a range of from 0.05 to 10 mg. 8. A tablet comprising a compound having a formula: ##STR00031## or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, diluent, or adjuvant. 9. The tablet of claim 8, wherein the tablet is coated with gelatin, wax, shellac, or sugar, or a combination thereof. 10. The tablet of claim 8, wherein the tablet comprises the compound having a formula: ##STR00032## 11. The tablet of claim 8, wherein the tablet comprises the compound having a formula: ##STR00033## 12. The tablet of claim 8, wherein the tablet comprises the compound having a formula: ##STR00034## in a range of from 0.0005 to 500 mg. 13. The tablet of claim 8, wherein the tablet comprises the compound having a formula: ##STR00035## in a range of from 0.01 to 50 mg. 14. The tablet of claim 8, wherein the tablet comprises the compound having a formula: ##STR00036## in a range of from 0.05 to 10 mg. 15. A pill comprising a compound having a formula: ##STR00037## or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, diluent, or adjuvant. 16. The pill of claim 15, wherein the pill is coated with gelatin, wax, shellac, or sugar, or a combination thereof. 17. The pill of claim 15, wherein the pill comprises the compound having a formula: ##STR00038## 18. The pill of claim 15, wherein the pill comprises the compound having a formula: ##STR00039## 19. The pill of claim 15, wherein the pill comprises the compound having a formula: ##STR00040## in a range of from 0.0005 to 500 mg. 20. The pill of claim 15, wherein the pill comprises the compound having a formula: ##STR00041## in a range of from 0.01 to 50 mg. 21. The pill of claim 15, wherein the pill comprises the compound having a formula: ##STR00042## in a range of from 0.05 to 10 mg. |